Figure 2.
Levels of transforming growth factor α (TGFα) (A), osteopontin (OPN) (B), osteocalcin (OCN) (C), parathyroid hormone (PTH) (D), and osteoprotegerin (OPG) (E) in the peri-implant fluid (pg/mL) in immediately loaded and nonloaded implants during the evaluation periods.
Asterisk (*) indicates a statistically significant difference between the groups (Mann-Whitney test, p < .05); lowercase letters indicate a statistically significant difference among the periods of evaluation within each group (Friedman test, p < .05).